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Strengths and limitations of this study
 ► This is the first systematic review to synthesise the 
totality of evidence regarding non- pharmacological 
rehabilitation interventions which improve cognitive 
deficits post- stroke.
 ► Robust and transparent methods used to identify, 
select, appraise and synthesise findings.
 ► Reporting in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses statement.
 ► Methodological quality assessed using Cochrane 
Risk of Bias tool.
 ► Pharmacological interventions to address cognition 
poststroke will not be included.
AbStrACt
Introduction Stroke is among the leading causes of 
death and disability worldwide. Poststroke cognitive 
impairment is a common sequela of stroke. The burden of 
cognitive impairment poststroke has significant impacts 
on the individual poststroke, their family and wider 
society. Despite the prevalence and associated burden of 
poststroke cognitive impairment, the optimal approach 
to rehabilitate cognitive deficits poststroke has yet to 
be established. A range of conservative interventions 
for cognitive impairment poststroke exist including 
self- efficacy training, physical activity interventions, 
neuropsychological interventions, electronic interventions, 
music therapy and occupational therapies. This systematic 
review aims to explore the totality of evidence with regard 
to non- pharmacological rehabilitation interventions 
wherein the primary or secondary aim is to improve 
cognitive function in individuals poststroke.
Methods and analysis A systematic review of 
randomised controlled trials which investigate the 
effectiveness of interventions wherein the primary 
or secondary aim is to improve cognitive function in 
individuals poststroke will be conducted (August 2019). 
The following electronic databases will be searched: 
PubMed, Embase, CINAHL, CENTRAL and PsycInfo. 
Reference lists of all identified studies will be reviewed 
to identify additional studies for inclusion. Titles and 
abstracts will be screened independently by two review 
authors for inclusion and exclusion. Any disagreement 
regarding inclusion will be resolved by discussion or by 
referral to a third assessor if necessary. Methodological 
quality will be assessed using the Cochrane Risk of Bias 
Tool for Randomised Controlled Trials. Meta- analyses will 
be performed if studies are sufficiently homogeneous. 
The review will be reported in accordance to the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses statement.
Ethics and dissemination As this systematic review 
will collect secondary data only, ethical approval is 
not required. Findings will be disseminated through 
presentations and peer- reviewed journals.
trial registration number CRD42019125289.
IntroduCtIon
Stroke is among the leading causes of 
disability worldwide.1 The prevalence of 
stroke survivors is projected to increase given 
advancements in acute stroke care services 
in conjunction with an ageing world popula-
tion.2 Given the increased prevalence of indi-
viduals surviving a stroke, coupled with an 
increase in the number of disability- adjusted 
life-years, stroke rehabilitation and the 
prevention of stroke- related residual disability 
have become increasingly important. Cogni-
tive impairment is a common clinical feature 
of stroke reported in 56.6% of ischaemic 
stroke survivors at 6 months poststroke.3 The 
presence of cognitive impairment poststroke 
is independently associated with lower quality 
of life at 12 months poststroke,4 higher levels 
of death and institutionalisation,5 increased 
carer burden6 and increased healthcare 
costs.7
A collaboration of stroke survivors, carers 
and healthcare professionals within the James 
Lind Alliance (UK) identified that optimum 
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approaches to improve cognitive impairment poststroke 
were among the top 10 research priorities with regard 
to life after stroke.8 This finding is also supported by 
the Intercollegiate Stroke Working Party national clin-
ical guidelines for stroke where it is acknowledged that 
although there have been developments within stroke 
rehabilitation literature; significant gaps exist in relation 
to cognition after stroke.9 Furthermore, a meta- summary 
of qualitative studies regarding stroke survivors’ experi-
ences of rehabilitation found that individuals with stroke 
report an emphasis placed on the rehabilitation of phys-
ical deficits with a neglect towards non- physical needs 
such as social re- integration and psychological support 
poststroke.10
As illustrated by the diversity and range of neuro-
psychological assessments, cognition is not a unitary 
concept.11 Cognitive impairment poststroke encompasses 
a variety of deficits across multiple domains and typically 
includes memory, attention, executive function, language 
and visuoperceptual ability.12 Various cognitive domains 
enable complex mental processes to occur which allow 
an individual to select and process information within 
their environment.13 Given the complex nature of cogni-
tive functioning, a broad range of interventions exist to 
improve cognitive function in individuals poststroke. 
Such interventions include, but are not restricted to, 
music therapy, resistance exercise training, aerobic 
exercise training, repetitive transcranial magnetic stim-
ulation, occupational therapies, neuropsychological 
interventions, cognitive strategy training, self- efficacy 
training, virtual reality training, cognitive computer-
ised training and electroacupuncture interventions.14 
Much of the previous research in this area has examined 
specific cognitive rehabilitation interventions on single 
domains of cognition poststroke. Six Cochrane reviews 
have explored the effectiveness of specific cognitive reha-
bilitation interventions on specific domains of cogni-
tive function poststroke.15–20 Cognitive rehabilitation is 
defined as ‘a systematic functionally orientated interven-
tion of therapeutic cognitive activities based on the assess-
ment and understanding of the patient's brain behaviour 
deficits’.13 There is a need to capture a broader range of 
interventions other than specific cognitive rehabilitation 
interventions with regard to improving cognitive func-
tion poststroke. Moreover, the effectiveness of interven-
tions across multiple domains of cognitive function needs 
to be investigated, given the diffuse nature of cognitive 
impairment poststroke.21 Studies focusing on the reha-
bilitation of single cognitive domains fail to capture the 
interrelated and highly overlapping nature of cognitive 
domains.11
In consideration of the effect of interventions other 
than specific cognitive rehabilitation interventions on 
cognitive impairment poststroke, ‘cognitive rehabil-
itation’ is arguably too narrow a term to use regarding 
the remediation cognitive impairment poststroke. 
Rather, there should be a focus on the broader picture 
of the rehabilitation of cognitive deficits poststroke. The 
efficacy of all types of non- pharmacological rehabilitation 
interventions on cognitive deficits poststroke needs to be 
investigated. The breadth of interventions identified will 
capture the totality of evidence with regard to all types 
of non- pharmacological rehabilitation interventions to 
rehabilitate cognitive deficits in individuals poststroke. 
Furthermore, given the diffuse nature of cognitive defi-
cits poststroke, there is a need to investigate the effects of 
interventions across all domains of cognition poststroke 
as opposed to focusing on domain- specific cognitive 
deficits.
In contrast with previous literature which has focused 
on specific single- domain cognitive rehabilitation 
interventions, this review will include all forms of non- 
pharmacological rehabilitation interventions wherein 
the primary or secondary aim is to improve cognitive 
function poststroke. Randomised controlled trials of 
interventions wherein the primary or secondary aim is 
to improve cognitive function in individuals poststroke 
will be evaluated. In the context of this review, cognition 
will include general cognitive function as assessed by a 
standardised cognitive screening assessment. The review 
will also capture deficits across the domains of attention, 
memory, executive function, perception, limb apraxia 
and neglect as outlined in the latest Australian Clinical 
Guidelines for Stroke (2017). To this end, this review aims 
to examine the totality of evidence with regard to non- 
pharmacological rehabilitation interventions wherein the 
primary or secondary aim is to improve cognitive func-
tion in individuals poststroke.
MEthodS
Study design
The current systematic review protocol is reported 
according to the Preferred Reporting Items for System-
atic Review and Meta- Analysis Protocols (PRISMA- P).22 In 
accordance with the PRISMA- P guidelines, this protocol 
was registered with the International Prospective Register 
of Systematic Reviews on 13 February 2019.
Eligibility criteria
Types of study
Randomised controlled trials and quasi- randomised 
control trials will be included, as defined by the Cochrane 
Handbook for Systematic Reviews of Interventions.23 
The precrossover component of randomised and quasi- 
randomised crossover trials will also be included, as will 
cluster trials. Studies published in the English language 
with full text available will be included.
Participants
Adults aged 18 years or older with a clinical diagnosis of 
ischaemic or haemorrhagic stroke are eligible for inclu-
sion. Individuals with a confirmed cognitive impairment 
poststroke as specified by the authors within each trial will 
be included. Individuals may be in the acute, subacute or 
chronic stage poststroke.
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Mixed aetiology studies (eg, traumatic brain injury and 
stroke mix) will be included if separate data are reported 
on individuals with stroke which can be clearly extracted 
for review. Participants post- transient ischaemic attack will 
be excluded, as will patients with dementia and patients 
with delirium. Individuals with cognitive impairment 
diagnosed before stroke onset will also be excluded.
Interventions
Interventions of which the primary or secondary aim is to 
improve cognitive function after stroke will be included. 
Interventions may focus on general cognitive function as 
assessed by a standardised cognitive screening assessment 
such as Mini- Mental State Examination (MMSE) score, 
Montreal Cognitive Assessment scale (MoCA) score, 
the Addenbrooke Cognitive Examination (ACE). Inter-
ventions may also focus on cognitive in relation to the 
following cognitive domains: executive function, atten-
tion, memory, perception, limb apraxia and neglect as 
outlined in the Australian Clinical Guidelines for Stroke 
Management (2017).
Interventions may be of any type or duration or time 
since stroke. Some anticipated interventions may include, 
but are not restricted to:
 ► Neuropsychological interventions.
 ► Exercise interventions: aerobic training, resistance 
training, flexibility training, balance training, Tai Chi.
 ► Electronic interventions, for example, use of iPads, 
mobile phone apps.
 ► Self- efficacy training.
 ► Patient education interventions.
 ► Cognitive rehabilitation interventions.
 ► Virtual reality training.
 ► Cognitive computerised training.
 ► Acupuncture/electroacupuncture interventions.
 ► Non- invasive brain stimulation.
Controls
Eligible control groups include:
Passive controls
 ► Usual/standard care control.
 ► No treatment control.
 ► Wait- list control.
Active controls
 ► Comparing different forms of interventions which are 
hypothesised to mediate improvements in cognitive 
function poststroke.
outcomes
The primary outcome is change in cognitive function 
post intervention in individuals with poststroke cognitive 
impairment. Outcome measures may focus on a domain- 
specific aspect of cognition such as executive function, 
attention, memory, perception, limb apraxia and neglect 
as outlined in the Australian Clinical Guidelines for 
Stroke Management (2017). Outcome measures may also 
cover a range of different cognitive functions in a single 
measure or give a measure of general cognitive status also.
Secondary outcome measures include quality of life, 
functional abilities, physical fitness, mobility, mood, 
participation and return to work.
Anticipated outcome measures include, but are not 
restricted to:
 ► Standardised tests or cognitive screening tools which 
provide a general cognitive function score, for 
example, MMSE, MOCA, ACE.
 ► Subjective cognitive function, for example, cognitive 
failures questionnaire.
 ► Neuropsychological test batteries.
 ► Performance tests, for example, the Trail- Making 
Test, the Clock Drawing Test.
 ► Functional assessments, for example, personal/
domestic Activities of Daily Living, community- based 
tasks, assessment of motor and process skills, func-
tional independence measure or functional assess-
ment measure.
Pharmacological interventions (including over- the- 
counter medications) will be excluded.
Public and patient involvement
No patient involved.
Search
The following electronic databases will be searched: 
PubMed, Embase, CENTRAL, PsycInfo and CINAHL 
(August 2019). The search strategy was developed in 
consultation with an academic librarian (LD, University 
of Limerick). The search strategy includes search terms 
relating to the population of interest (individuals post-
stroke), the intervention (breadth of rehabilitation inter-
ventions as described), study type (randomised controlled 
trials) and the primary outcome of interest (change in 
cognitive function poststroke). To illustrate, the full elec-
tronic database search string for the CINAHL database is 
detailed in online supplementary appendix 1.
Reference lists of included studies will be searched to 
identify potentially eligible studies and authors of key 
texts may be contacted as appropriate. Forward citations 
on included studies will be checked. Clinical  Trials. gov 
and the Vista database will be searched for potentially 
eligible ongoing trials.
data selection
The search results from each individual database will 
be saved in a master reference management library 
(EndnoteX7) and duplicates will be removed. Titles and 
abstracts of the citations retrieved by the literature search 
will be screened independently by two review authors 
(MOD, RG) for inclusion or exclusion using Rayyan 
QCRI. The full text of potentially relevant studies will 
be selected for further assessment and two independent 
authors will ascertain and agree on eligibility based on 
the full article (RG, MOD). Any disagreement regarding 
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inclusion will be resolved by discussion, or by referral to a 
third assessor (PB) if necessary.
Results of the screening process will be detailed in a 
PRISMA flow diagram.
data extraction
Data will be extracted and entered into a standardised 
recording data extraction form. Data including author, 
study design, population characteristics (age, gender, 
type of stroke, severity of stroke), intervention character-
istics (intervention type, intervention content, duration 
of intervention, method of delivery, setting of interven-
tion, length of follow- up), control group (passive, active), 
primary and secondary outcomes at postinterventions 
and follow- up, when available, will be extracted.
Data including the severity of cognitive impairment, 
type of cognitive impairment (ie, domain(s) of cognition 
affected), neuropsychological underpinnings of cognitive 
impairment, means(assessment) of formal diagnosis of 
cognitive impairment, definition of cognition/cognitive 
impairment poststroke within each study, where available, 
will be extracted.
Both the stage poststroke (acute, subacute and chronic) 
and the severity of cognitive impairment (mild, moderate, 
severe) will be considered within the context of each indi-
vidual study and reported descriptively. The theoretical 
basis of the intervention/mechanisms by which these 
interventions mediated cognitive improvement post-
stroke will also be documented. In consideration of the 
association between language impairments and perfor-
mance on cognitive assessments, the language effects of 
primary outcome measures will be extracted.
Study authors will be contacted for missing data if 
necessary.
risk of bias
The internal and external validity of studies will be 
assessed by two independent reviewers (MOD, SH) using 
the Cochrane Risk of Bias Tool in accordance with the 
following domains: selection bias, performance bias, 
detection bias, attrition bias, reporting bias and any 
other sources of bias.23 Disagreements will be resolved by 
consensus among two other reviewers (RG, PB). Disagree-
ments among the review authors on the methodological 
quality of the identified studies will be discussed and 
resolved by group consensus.
Strategy for data synthesis
We will perform separate analyses for trials comparing 
interventions to reduce cognitive impairment with 
‘treatment as usual’, or with a ‘placebo’ control inter-
vention, and trials comparing two active interventions. 
The Cochrane Review Manager software (RevMan) will 
be used to conduct statistical analyses to determine the 
treatment effect. For continuous data, we will calculate 
the treatment effect using mean differences (SMD) and 
95% CI where different studies used different scales to 
assess the same outcome, and calculate SMD and 95% CI 
where studies have all used the same method of measuring 
outcome.
Due to the breadth of both interventions and cognitive 
outcome measures, it may be difficult to synthesise the 
data across studies. The impact of heterogeneity on results 
will be assessed using the I2 statistic. When the I2 is <30% 
there is little concern about statistical heterogeneity.23 If 
there is statistical heterogeneity ≥50% we will use random- 
effects models to take account of the between- study varia-
tion in our findings.23
If meta- analysis is not possible as a result of substantial 
heterogeneity, a narrative synthesis of findings from the 
included studies will be provided.
Subgroup analysis
If a sufficient number of randomised controlled trials 
are identified, subgroup analyses will be conducted to 
establish the effect of the following subgroups on overall 
outcomes:
 ► Participant- related characteristics, for example, age of 
individuals with stroke (<65 vs >65); type and severity 
of stroke; time since stroke onset; severity of cognitive 
impairment; effect of depression and/ or fatigue on 
cognitive function; adherence to intervention.
 ► Intervention- related characteristics, for example, 
type of intervention: individual vs group training, 
self- efficacy training versus aerobic exercise training; 
impact of healthcare professionals on intervention 
outcomes; frequency, intensity, time and type of 
intervention.
 ► Outcome- related characteristics, for example, type 
of cognitive outcome assessed (including potential 
effects of language impairment on performance of 
the test), global cognitive outcome versus domain- 
specific outcome.
dISCuSSIon
This systematic review and meta- analysis will use a rigorous 
methodology to provide up- to- date evidence regarding 
the effectiveness of all types of non- pharmacological 
rehabilitation interventions on cognitive function post-
stroke. Given the breadth of interventions shown to have 
an effect on poststroke cognitive impairment, there is a 
need to investigate all interventions, not solely cognitive 
rehabilitation interventions, which may mediate improve-
ments in cognitive function poststroke. Previous research 
has taken a domain- specific approach to evaluating the 
effectiveness of cognitive rehabilitation interventions on 
cognitive deficits poststroke. Given the diffuse nature of 
poststroke cognitive impairment, the effectiveness of all 
types of non- pharmacological rehabilitation interven-
tions across multiple domains of cognitive functioning 
poststroke needs to be investigated. A rigorous review of 
the effectiveness of all non- pharmacological rehabilita-
tion interventions with regard to cognitive impairment 
poststroke is therefore needed.
The results of this review will inform the optimal type 
of intervention to rehabilitate cognitive impairment 
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poststroke including information on frequency, intensity, 
type and delivery of interventions. This information will 
inform the development of an optimal intervention to 
rehabilitate cognitive impairment poststroke. In addition, 
if data prove to be sufficiently homogenous to conduct a 
meta- analysis, information regarding the expected effect 
size associated with each intervention may be made avail-
able to healthcare professionals. This will be of use to 
clinicians and policy- makers in their design and evalua-
tion of rehabilitation services aimed at improving cogni-
tive impairment poststroke.
EthICS And dISSEMInAtIon
Findings will be disseminated through publication in peer- 
reviewed journals and through conferences. The rigorous 
scrutiny of primary studies will identify the strengths and 
limitations of current research and will provide recom-
mendations for future research within this area.
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